Alpine Immune Sciences, Inc.
Hedge Funds Holdings
Last updated:
Alpine Immune Sciences, Inc.‘s stocks are currently a part of 27 hedge funds’ portfolios, which represents 10.86% of the total amount of its stocks outstanding. This makes up a total of 3.63M shares of Alpine Immune Sciences, Inc.. Compared to the previous quarter, the number fell by -89.39% or -30.58M shares fewer. As for the holding position changes, 59.26% (16) of current hedge fund investors increased the number of shares held, 22.22% (6) of current holders sold a part of the shares held, and 18.52% (5) closed the holdings completely. 2 hedge funds are new holders of Alpine Immune Sciences, Inc. stock in Q1 2023, it is 7.41% of total holders.
Hedge funds holding Alpine Immune Sciences (Q2 2018 – Q1 2023)
| Q2 2018 | 23 |
|---|---|
| Q3 2018 | 22 |
| Q4 2018 | 23 |
| Q1 2019 | 23 |
| Q2 2019 | 23 |
| Q3 2019 | 18 |
| Q4 2019 | 18 |
| Q1 2020 | 15 |
| Q2 2020 | 19 |
| Q3 2020 | 34 |
| Q4 2020 | 43 |
| Q1 2021 | 47 |
| Q2 2021 | 47 |
| Q3 2021 | 44 |
| Q4 2021 | 52 |
| Q1 2022 | 55 |
| Q2 2022 | 57 |
| Q3 2022 | 67 |
| Q4 2022 | 62 |
| Q1 2023 | 27 |
Hedge funds changes in Alpine Immune Sciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 1 | 9 | 4 | 6 | 3 |
|---|---|---|---|---|---|
| Q3 2018 | 2 | 6 | 6 | 3 | 5 |
| Q4 2018 | 3 | 3 | 7 | 2 | 8 |
| Q1 2019 | 3 | 7 | 8 | 3 | 2 |
| Q2 2019 | 2 | 6 | 7 | 2 | 6 |
| Q3 2019 | 1 | 4 | 5 | 6 | 2 |
| Q4 2019 | 2 | 1 | 5 | 2 | 8 |
| Q1 2020 | 1 | 2 | 2 | 4 | 6 |
| Q2 2020 | 8 | 4 | 2 | 4 | 1 |
| Q3 2020 | 18 | 9 | 3 | 3 | 1 |
| Q4 2020 | 12 | 12 | 7 | 3 | 9 |
| Q1 2021 | 10 | 15 | 10 | 6 | 6 |
| Q2 2021 | 15 | 8 | 14 | 15 | -5 |
| Q3 2021 | 4 | 18 | 13 | 6 | 3 |
| Q4 2021 | 11 | 22 | 9 | 4 | 6 |
| Q1 2022 | 10 | 15 | 17 | 7 | 6 |
| Q2 2022 | 9 | 22 | 16 | 6 | 4 |
| Q3 2022 | 15 | 23 | 17 | 5 | 7 |
| Q4 2022 | 8 | 33 | 9 | 13 | -1 |
| Q1 2023 | 2 | 16 | 6 | 5 | -2 |
Hedge funds changes in Alpine Immune Sciences stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 27,000 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 0 | 1,000 |
| Q4 2022 | 8,085 | 735 |
| Q1 2023 | 0 | 0 |